Hong Kong · Delayed Price · Currency is HKD Kintor Pharmaceutical Statistics
Total Valuation
HKG:9939 has a market cap or net worth of HKD 807.38 million. The enterprise value is 925.46 million.
| Market Cap | 807.38M |
| Enterprise Value | 925.46M |
Important Dates
The next estimated earnings date is Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9939 has 493.81 million shares outstanding. The number of shares has increased by 10.84% in one year.
| Current Share Class | 493.81M |
| Shares Outstanding | 493.81M |
| Shares Change (YoY) | +10.84% |
| Shares Change (QoQ) | +5.99% |
| Owned by Insiders (%) | 12.11% |
| Owned by Institutions (%) | 3.79% |
| Float | 378.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.88 |
| PB Ratio | 6.40 |
| P/TBV Ratio | 51.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26, with a Debt / Equity ratio of 1.22.
| Current Ratio | 0.26 |
| Quick Ratio | 0.19 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.89 |
| Interest Coverage | -45.44 |
Financial Efficiency
Return on equity (ROE) is -118.45% and return on invested capital (ROIC) is -39.43%.
| Return on Equity (ROE) | -118.45% |
| Return on Assets (ROA) | -30.30% |
| Return on Invested Capital (ROIC) | -39.43% |
| Return on Capital Employed (ROCE) | -126.66% |
| Weighted Average Cost of Capital (WACC) | 0.80% |
| Revenue Per Employee | 745,089 |
| Profits Per Employee | -1.82M |
| Employee Count | 122 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 6.40 |
Taxes
| Income Tax | -6.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.27% in the last 52 weeks. The beta is -0.68, so HKG:9939's price volatility has been lower than the market average.
| Beta (5Y) | -0.68 |
| 52-Week Price Change | -33.27% |
| 50-Day Moving Average | 1.80 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 37.17 |
| Average Volume (20 Days) | 593,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9939 had revenue of HKD 90.90 million and -222.38 million in losses. Loss per share was -0.46.
| Revenue | 90.90M |
| Gross Profit | 39.14M |
| Operating Income | -198.89M |
| Pretax Income | -228.84M |
| Net Income | -222.38M |
| EBITDA | -155.19M |
| EBIT | -198.89M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 36.13 million in cash and 154.22 million in debt, with a net cash position of -118.09 million or -0.24 per share.
| Cash & Cash Equivalents | 36.13M |
| Total Debt | 154.22M |
| Net Cash | -118.09M |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 126.10M |
| Book Value Per Share | 0.25 |
| Working Capital | -155.43M |
Cash Flow
In the last 12 months, operating cash flow was -174.22 million and capital expenditures 151,236, giving a free cash flow of -174.07 million.
| Operating Cash Flow | -174.22M |
| Capital Expenditures | 151,236 |
| Depreciation & Amortization | 44.39M |
| Net Borrowing | 52.15M |
| Free Cash Flow | -174.07M |
| FCF Per Share | -0.35 |
Margins
Gross margin is 43.05%, with operating and profit margins of -218.80% and -244.64%.
| Gross Margin | 43.05% |
| Operating Margin | -218.80% |
| Pretax Margin | -251.75% |
| Profit Margin | -244.64% |
| EBITDA Margin | -170.73% |
| EBIT Margin | -218.80% |
| FCF Margin | n/a |
Dividends & Yields
HKG:9939 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.84% |
| Shareholder Yield | -10.84% |
| Earnings Yield | -27.54% |
| FCF Yield | -21.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:9939 has an Altman Z-Score of -17.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.59 |
| Piotroski F-Score | 3 |